Home › Ulcerative Colitis › New Jersey
Ulcerative Colitis clinical trials in New Jersey
7 studies for Ulcerative Colitis are looking for participants at sites in New Jersey.
Cities in New Jersey
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-014, Clifton
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07845487Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Virtua Health & Wellness Center - Moorestown, Moorestown
- Saint Peter's University Hospital, New Brunswick
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07415044A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Goryeb Children's Hospital /ID# 271801, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 22, 2026 · NCT07071519An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Sanmora Bespoke Clinical Research Solutions LLC - Site Number: 8400123, East Orange
- Allied Health Clinical Research Organization, LLC - Freehold - Site Number: 8400014, Freehold
- Allied Health Clinical Research Organization, LLC - Jackson - Site Number: 8400007, Jackson
- and 2 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Virtua Health, Marlton
RecruitingObservational study
Ages 18 to 64 · All sexes · Updated Jul 9, 2026 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Atlantic Health - Morristown Medical Center, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Jun 22, 2026 · NCT06405087From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.